Clinical Data Beam posts positive data on base editing treatment for AATD BioPharma DiveUpdated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.Clinical DataRare DiseaseRead full story pharminent March 25, 2026 (Last updated: March 26, 2026) BioPharma Dive Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study. Clinical DataRare DiseaseRead full story Post navigation Previous: Sarepta sees early success with RNAi drugs from ArrowheadNext: Maze tumbles despite positive data for kidney disease drug Related Stories Clinical Data Novartis hit as Lp(a) drug fails cardio outcomes trial pharminent September 7, 2026 Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe pharminent September 7, 2026 Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026